Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir

RELATION BETWEEN SERUM-FREE-FATTY-ACIDS AND ARRHYTHMIAS AND DEATH AFTER ACUTE MYOCARDIAL INFARCTION

M. F. Oliver · The Lancet · 1968 · 521 citations

Metabolic Syndrome, Cardiovascular Disease, Omega-3 Fatty Acid +6

Coenzyme A and carnitine distribution in normal and ischemic hearts.

J.A. Idell-Wenger, Lee W. Grotyohann, J. R. Neely · Journal of Biological Chemistry · 1978 · 478 citations · Full text

Cardiac Muscle, Heart Failure, Carnitine Distribution +16

Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine.

A. J. Liedtke, S. H. Nellis, J. R. Neely · Circulation Research · 1978 · 287 citations · Full text

Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.

G.D. Lopaschuk, Stephen R. Wall, Peter M. Olley et al. · Circulation Research · 1988 · 286 citations

Cardiovascular Toxicity, Metabolic Syndrome, Carnitine Palmitoyltransferase +15

Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium.

A. J. Liedtke, Luc Demaison, A. M. Eggleston et al. · Circulation Research · 1988 · 223 citations · Full text

Cardiac Muscle, Heart Failure, Metabolic Remodeling +19